Lantheus Holdings, Inc. Shareholders' Equity
Lantheus Holdings, Inc. (LNTH) had Shareholders' Equity of $1.31 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $1.31B.
- 2026-03-31: Stockholders' Equity Attributable to Parent $1.21B.
- 2025-12-31: Stockholders' Equity Attributable to Parent $1.09B.
- 2025-09-30: Stockholders' Equity Attributable to Parent $1.12B.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $1.31B 10-Q · filed 2026-08-06 |
| 2026-03-31 | $1.21B 10-Q · filed 2026-08-06 |
| 2025-12-31 | $1.09B 10-Q · filed 2026-08-06 |
| 2025-09-30 | $1.12B 10-Q · filed 2025-11-06 |
| 2025-06-30 | $1.17B 10-Q · filed 2026-08-06 |
| 2025-03-31 | $1.16B 10-Q · filed 2026-08-06 |
| 2024-12-31 | $1.09B 10-Q · filed 2026-08-06 |
| 2024-09-30 | $1.18B 10-Q · filed 2025-11-06 |
| 2024-06-30 | $1.03B 10-Q · filed 2025-11-06 |
| 2024-03-31 | $945.54M 10-Q · filed 2025-11-06 |
| 2023-12-31 | $815.89M 10-K · filed 2026-02-26 |
| 2023-09-30 | $698.76M 10-Q · filed 2024-11-06 |
| 2023-06-30 | $552.64M 10-Q · filed 2024-11-06 |
| 2023-03-31 | $445.52M 10-Q · filed 2024-11-06 |
| 2022-12-31 | $447.15M 10-K · filed 2026-02-26 |
| 2022-09-30 | $638.05M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $567.33M 10-Q · filed 2023-11-02 |
| 2022-03-31 | $515.85M 10-Q · filed 2023-11-02 |
| 2021-12-31 | $464.44M 10-K · filed 2025-02-26 |
| 2021-09-30 | $499.34M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $508.14M 10-Q · filed 2022-11-03 |
| 2021-03-31 | $528.12M 10-Q · filed 2022-11-03 |
| 2020-12-31 | $514.21M 10-K · filed 2024-02-22 |
| 2020-09-30 | $513.58M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $515.58M 10-Q · filed 2021-11-04 |
| 2020-03-31 | $118.40M 10-Q · filed 2021-11-04 |
| 2019-12-31 | $114.60M 10-K · filed 2023-02-23 |
| 2019-09-30 | $101.17M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $92.25M 10-Q · filed 2020-11-05 |
| 2019-03-31 | $83.21M 10-Q · filed 2020-11-05 |
| 2018-12-31 | $71.00M 10-K · filed 2022-02-24 |
| 2018-09-30 | $55.51M 10-Q · filed 2019-10-31 |
| 2018-06-30 | $44.53M 10-Q · filed 2019-10-31 |
| 2018-03-31 | $33.66M 10-Q · filed 2019-10-31 |
| 2017-12-31 | $23.29M 10-K · filed 2021-02-25 |
| 2017-09-30 | -$77.92M 10-Q · filed 2017-11-02 |
| 2017-06-30 | -$87.18M 10-Q · filed 2017-08-01 |
| 2017-03-31 | -$101.16M 10-Q · filed 2017-05-02 |
| 2016-12-31 | -$106.52M 10-K · filed 2020-02-25 |
| 2016-09-30 | -$121.16M 10-Q · filed 2016-11-01 |
| 2016-06-30 | -$166.37M 10-Q · filed 2016-08-04 |
| 2016-03-31 | -$174.22M 10-Q · filed 2016-05-03 |
| 2015-12-31 | -$185.29M 10-K · filed 2019-02-20 |
| 2015-09-30 | -$190.15M 10-Q · filed 2015-11-04 |
| 2015-06-30 | -$195.58M 10-Q · filed 2015-08-05 |
| 2014-12-31 | -$239.27M 10-K · filed 2018-02-26 |
| 2013-12-31 | -$235.52M 10-K · filed 2017-02-23 |
| 2012-12-31 | -$173.10M 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |